李佳钰，刘瑞金，于凯江. 半胱氨酸蛋白酶在脓毒症中的研究进展[J]. 中国急救医学, 2019, 39(4): 398-400.
Li Jia-yu, Liu Rui-jin, Yu Kai-jiang. Research progress of Caspase in sepsis. Chinese Journal of Critical Care Medicine, 2019, 39(4): 398-400.
［1］Lakshmikanth CL, Jacob SP, Chaithra VH, et al. Sepsis: in search of cure［J］. Inflamm Res, 2016, 65(8): 587-602.
［2］Nolan A, Weiden MD. Trends in sepsis and infection sources in the United States. A population-based study［J］. Ann Am Thorac Soc, 2015, 12(5): 784.
［3］Aziz M, Jacob A, Wang P. Revisiting caspases in sepsis［J］. Cell Death Dis, 2014, 11(5): e1526.
［4］Khalilzadeh B, Shadjou N, Kanberoglu GS, et al. Advances in nanomaterial based optical biosensing and bioimaging of apoptosis via caspase-3 activity: a review［J］. Mikrochim Acta, 2018, 185(9): 434.
［5］Wang YC, Liu QX, Liu T, et al. Caspase-1-dependent pyroptosis of peripheral blood mononuclear cells predicts the development of sepsis in severe trauma patients: A prospective observational study［J］. Medicine (Baltimore), 2018, 97(8): e9859.
［6］Weng D, Marty-Roix R, Ganesan S, et al. Caspase-8 and RIP kinases regulate bacteria-induced innate immune responses and cell death［J］. Proc Natl Acad Sci USA, 2014, 111(20): 7391-7396.
［7］Lee H, Shin EA, Lee JH, et al. Caspase inhibitors: a review of recently patented compounds (2013-2015)［J］. Expert Opin Ther Pat, 2018, 28(1): 47-59.
［8］Su H, Bidere N, Zheng L, et al. Requirement for caspase-8 in NF-kappa B activation by antigen receptor［J］. Science, 2005, 307(5714): 1465-1468.
［9］Yan B, Wei K, Hou L, et al. Receptor-Interacting Protein 3/Caspase-8 May Regulate Inflammatory Response and Promote Tissue Regeneration in the Periodontal Microenvironment［J］. Med Sci Monit, 2018, 24: 5247-5257.
［10］Sagulenko V, Lawlor KE, Vince JE. New insights into the regulation of innate immunity by caspase-8［J］. Arthritis Res Ther, 2016, 13, 18: 4.
［11］Shimizu T, Nakazato T, Xian MJ, et al. Resveratrol induces apoptosis of human malignant B cells by activation of caspase-3 and p38 MAP kinase pathways［J］. Biochem Pharmacol, 2006, 71(6): 742-750.
［12］Parlato M, Souza-Fonseca-Guimaraes F, Philippart F, et al. CD24-triggered caspase-dependent apoptosis via mitochondrial membrane depolarization and reactive oxygen species production of human neutrophils is impaired in sepsis［J］. J Immunol, 2014, 192(5): 2449-2459.
［13］Exline MC, Justiniano S, Hollyfield JL, et al. Microvesicular caspase-1 mediates lymphocyte apoptosis in sepsis［J］. PLoS One, 2014, 9(3): e90 968.
［14］Hu Z, Murakami T, Suzuki K, et al. Antimicrobial cathelicidin peptide LL-37 inhibits the LPS/ATP-induced pyroptosis of macrophagesby dual mechanism［J］. PLoS One, 2014, 9(1): e85 765.
［15］Vanden Berghe T, Demon D, Bogaert P, et al. Simultaneous targeting of IL-1 and IL-18 is required for protection against inflammatory and septicshock［J］. Am J Respir Crit Care Med, 2014, 189(3): 282-291.
［16］Aachoui Y, Sagulenko V, Miao EA, et al. Inflammasome-mediated pyroptotic and apoptotic cell death, and defense against infection［J］. Curr Opin Microbiol, 2013, 16(3): 319-326.
［17］Sarkar A, Balakrishnan K, Chen J, et al. Molecular evidence of Zn chelation of the procaspase activating compound B-PAC-1 in B cell lymphoma［J］. Oncotarget, 2016, 7(3): 3461-3476.
［18］Hagar JA, Miao EA. Detection of cytosolic bacteria by inflammatory caspases［J］. Curr Opin Microbiol, 2014, 17: 61-66.
［19］Larios Mora A, Detalle L, Gallup JM, et al. Delivery of ALX-0171 by inhalation greatly reduces respiratory syncytial virus disease in newborn lambs［J］. MAbs, 2018, 10(5): 778-795.
［20］Chen H, Fang Y, Wu J, et al. RIPK3-MLKL-mediated necroinflammation contributes to AKI progression to CKD［J］. Cell D eath Dis, 2018, 9(9): 878.
［21］Duprez L, Takahashi N, Van Hauwermeiren F, et al. RIP kinase-dependent necrosis drives lethal systemic inflammatory response syndrome［J］. Immunity, 2011, 35(6): 908-918.
［22］Hutchins NA, Unsinger J, Hotchkiss RS, et al. The new normal: immunomodulatory agents against sepsis immune suppression［J］. Trends Mol Med, 2014, 20(4): 224-233.
